$84,67
▲ +$1,29
(+1,55%)
Vol. 640K
11
Punteggio di Qualità
ok
Analisi approfondita
2/5
ok
Ricavi ✓
Utile netto ✓
>IPO ✗
Cap. mercato
$7.8B
P/E
40,8
ROE
9,0%
Margine
14,9%
D/E
46,02
Beta
0,23
52W
$74–$117
Consenso Wall Street
20 analisti · Apr 20267
Acquisto forte
10
Compra
2
Mantieni
1
Vendi
0
Vendita forte
85,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 80,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $0,91 | $0,95 | +$0,04 |
| Dic 2025 | $0,94 | $1,01 | +$0,07 |
| Set 2025 | $0,93 | $1,08 | +$0,15 |
| Giu 2025 | $0,82 | $0,97 | +$0,15 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $300.4M | $311.8M | $330.8M | $325.8M | $322.2M |
| Utile netto | — | $5.7M | $26.4M | $53.9M | $59.9M | $51.7M |
Trend fondamentali
| Metrica | 2025-07-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 6.9% | 5.7% | 6.9% | 6.9% | 6.9% | 9.0% |
| P/E (TTM) | 57.52 | 63.85 | 55.99 | 55.88 | 58.42 | 40.80 |
| Net Margin | 18.4% | 9.8% | 11.5% | 11.5% | 11.5% | 14.9% |
| Gross Margin | 71.4% | 65.5% | 66.4% | 66.4% | 66.4% | 67.7% |
| D/E Ratio | 46.91 | 49.75 | 46.91 | 46.91 | 46.91 | 46.02 |
| Current Ratio | 4.23 | 4.06 | 4.23 | 4.23 | 4.23 | 4.13 |
Rapporti chiave
ROA (TTM)
5,6%
P/S (TTM)
6,06
P/B
4,5
EPS (TTM)
$2,18
CF/Share
$2,00
Crescita ricavi 3A
+16,6%
52W High
$116,65
52W Low
$74,07
$74,07
Intervallo 52 settimane
$116,65
Salute finanziaria
Flusso di cassa libero
$127.2M
Debito netto
$719.0M
Liquidità
$309.3M
Debito totale
$1.0B
Aggiornato al Ott 31, 2025
Як HQY виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка HQY vs аналоги Health Care
P/E
40,8
▲
33%
sopra
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
6,1
▲
135%
sopra
peer
(2,6)
vs Peer
vs Settore
Sopravvalutato
P/B
4,5
▲
63%
sopra
peer
(2,8)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість HQY vs аналоги Health Care
ROE
9,0%
▲
123%
sopra
peer
(-38,5%)
vs Peer
vs Settore
Top livello
Net margin
14,9%
▲
160%
sopra
peer
(-24,7%)
vs Peer
vs Settore
Top livello
Валова маржа
67,7%
▲
28%
sopra
peer
(52,9%)
vs Peer
vs Settore
Sotto media
ROA
5,6%
▲
126%
sopra
peer
(-21,2%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя HQY vs аналоги Health Care
D/E ratio
46,0
▲
139%
sopra
peer
(19,3)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
4,1
▲
91%
sopra
peer
(2,2)
vs Peer
vs Settore
Liquidità forte
Beta
0,2
▼
78%
sotto
peer
(1,1)
vs Peer
vs Settore
Più volatile
Радар фундаменталів HQY
HQY
Mediana peer
Industria
HQY прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
HQY vs аналоги: ключові метрики
Segnali Correlati
Attività insider
NeutralAcquisti
0
Vendite
0
ROSNER ELIMELECH
Chief Technology Officer · Mar 25
60607 shs
FIORE MICHAEL HENRY
Officer · Mar 25
17582 shs
GATHRIGHT MICHAEL
Officer · Mar 25
15157 shs
LUCANIA JAMES M
Chief Financial Officer · Mar 25
27283 shs
LADD DELANO W IV
General Counsel · Mar 25
35608 shs
CUTLER SCOTT RAYMOND
Chief Executive Officer · Mar 25
72754 shs
NEELEMAN STEPHEN
Officer and Director · Mar 25
39775 shs
PARKER STUART B
Director · Feb 02
1263 shs
NATARAJAN RAJESH
Director · Feb 02
976 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 37,61%Blackrock Inc.
13,28%
$926.9M
Vanguard Group Inc
10,26%
$716.4M
Wasatch Advisors LP
7,80%
$544.6M
State Street Corporation
3,66%
$255.5M
Geode Capital Management, L…
2,61%
$181.9M
Aggiornato al Dic 31, 2025